FCF Life Sciences Venture Capital Monitor – Europe 04/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2021”.

The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

As of the end of April 2021 we identify the following current VC trends in Europe:

  • In 2021, overall Life Sciences funding has reached EUR 4,288m so far
  • Top 5 Deals exceed EUR 140m each, largest transaction amounted to
    EUR 253m in Kry International AB (Sweden)
  • BlackRock (USA) still dominates the Top 5 Investors (by deal volume), followed by Fidelity Management & Research (USA) and Novo Holdings (Denmark)
  • The Biotechnology sector received 65% of the total investment volume (-11% points compared to the previous month)
  • Central Nervous System replaces Oncology as the top indication

To access the full report, please click here.

By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn

Share on linkedin
Scroll Up